SM
CSCI
Sabby Management’s COSCIENS Biopharma Inc. Common Stock CSCI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-244,240
| Closed | -$214K | – | 131 |
|
|
2021
Q2 | $214K | Sell |
244,240
-354,202
| -59% | -$310K | 0.03% | 73 |
|
|
2021
Q1 | $682K | Buy |
+598,442
| New | +$682K | 0.13% | 47 |
|
|
2020
Q1 | – | Sell |
-101,976
| Closed | -$93K | – | 84 |
|
|
2019
Q4 | $93K | Buy |
101,976
+29,900
| +41% | +$27.3K | 0.03% | 41 |
|
|
2019
Q3 | $74K | Buy |
72,076
+59,277
| +463% | +$60.9K | 0.04% | 57 |
|
|
2019
Q2 | $38K | Buy |
+12,799
| New | +$38K | 0.05% | 59 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 102 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 114 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 126 |
|
|
2017
Q3 | – | Sell |
-67,283
| Closed | -$67K | – | 142 |
|
|
2017
Q2 | $67K | Buy |
+67,283
| New | +$67K | ﹤0.01% | 101 |
|
|
2017
Q1 | – | Sell |
-400,560
| Closed | -$1.44M | – | 196 |
|
|
2016
Q4 | $1.44M | Buy |
400,560
+333,578
| +498% | +$1.2M | 0.08% | 41 |
|
|
2016
Q3 | $230K | Sell |
66,982
-198,821
| -75% | -$683K | 0.01% | 123 |
|
|
2016
Q2 | $867K | Sell |
265,803
-226,682
| -46% | -$739K | 0.05% | 81 |
|
|
2016
Q1 | $1.64M | Sell |
492,485
-41,660
| -8% | -$138K | 0.08% | 59 |
|
|
2015
Q4 | $2.39M | Buy |
+534,145
| New | +$2.39M | 0.13% | 33 |
|